Understanding Nutritional Interventions and Physical Exercise in Non-Alcoholic Fatty Liver Disease

被引:35
作者
Ordonez, R. [1 ,2 ]
Carbajo-Pescador, S. [3 ]
Mauriz, J. L. [1 ,2 ]
Gonzalez-Gallego, J. [1 ,2 ]
机构
[1] Univ Leon, Ctr Invest Biomed Red Enfermedades Hepat & Digest, E-24071 Leon, Spain
[2] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain
[3] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA
关键词
Exercise; fat; liver; NAFLD; nutritional intervention; steatosis; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; ACID-BINDING PROTEIN; IMPROVES HEPATIC STEATOSIS; NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION; X-RECEPTOR LXR; INSULIN-RESISTANCE; OXIDATIVE STRESS; LIPID-ACCUMULATION;
D O I
10.2174/1566524015666150114110551
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in adults and its prevalence is rising around the world. This pathology is characterized by accumulation of liver fat, which exceeds 5% of liver weight in absence of alcohol consumption, viral infection or other hepatic etiology. Since NAFLD has been associated with obesity, insulin resistance, diabetes or alteration of lipid profiles, it is considered as the liver manifestation of metabolic syndrome. Pathogenic mechanisms of NAFLD have not been clearly elucidated, but different events such as lipid accumulation, insulin resistance, oxidative and endoplasmic reticulum stress, mitochondrial dysfunction and inflammation are involved. Modifications in lifestyle constitute the first line for the management of NAFLD. Nutritional interventions include low fat and carbohydrate diet with higher polyunsaturated fatty acids ingestion. Moreover, supplementation with antioxidant and cytoprotective agents could be useful to decrease oxidative stress, inflammation and fibrosis. Physical activity enables to reduce the expression of lipogenic genes, fat accumulation, or insulin resistance and improves cardiorespiratory fitness. Benefits have been found following both aerobic exercise and resistance training, and remain even after exercise cessation. However, more studies are required to analyze the molecular and cellular mechanisms involved in nutritional and physical intervention, and to define the volume of activity required and its association with weight loss. In this paper, we offer an updated overview of the mechanisms implicated in the progression of NAFLD, and analyze the beneficial effects of nutritional interventions and physical exercise in the prevention and treatment of this condition.
引用
收藏
页码:3 / 26
页数:24
相关论文
共 250 条
[1]   Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels [J].
Abbenhardt, C. ;
McTiernan, A. ;
Alfano, C. M. ;
Wener, M. H. ;
Campbell, K. L. ;
Duggan, C. ;
Foster-Schubert, K. E. ;
Kong, A. ;
Toriola, A. T. ;
Potter, J. D. ;
Mason, C. ;
Xiao, L. ;
Blackburn, G. L. ;
Bain, C. ;
Ulrich, C. M. .
JOURNAL OF INTERNAL MEDICINE, 2013, 274 (02) :163-175
[2]   Increased Fructose Consumption Is Associated with Fibrosis Severity in Patients with Nonalcoholic Fatty Liver Disease [J].
Abdelmalek, Manal F. ;
Suzuki, Ayako ;
Guy, Cynthia ;
Unalp-Arida, Aynur ;
Colvin, Ryan ;
Johnson, Richard J. ;
Diehl, Anna Mae .
HEPATOLOGY, 2010, 51 (06) :1961-1971
[3]   Betaine for Nonalcoholic Fatty Liver Disease: Results of a Randomized Placebo-Controlled Trial [J].
Abdelmalek, Manal F. ;
Sanderson, Schuyler O. ;
Angulo, Paul ;
Soldevila-Pico, Consuelo ;
Liu, Chen ;
Peter, Joy ;
Keach, Jill ;
Cave, Matt ;
Chen, Theresa ;
McClain, Craig J. ;
Lindor, Keith D. .
HEPATOLOGY, 2009, 50 (06) :1818-1826
[4]   Acetyl-CoA Carboxylase 2-/- Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions [J].
Abu-Elheiga, Lutfi ;
Wu, Hongmei ;
Gu, Ziwei ;
Bressler, Rubin ;
Wakil, Salih J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (15) :12578-12588
[5]   Nonalcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P ;
Lindor, KD .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) :899-905
[6]   A pilot trial of pentoxifylline in nonalcoholic steatohepatitis [J].
Adams, LA ;
Zein, CO ;
Angulo, P ;
Lindor, KD .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2365-2368
[7]   Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis [J].
Alisi, A. ;
Bedogni, G. ;
Baviera, G. ;
Giorgio, V. ;
Porro, E. ;
Paris, C. ;
Giammaria, P. ;
Reali, L. ;
Anania, F. ;
Nobili, V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) :1276-1285
[8]   Non-Alcoholic Steatohepatitis: What Can We Learn from Animal Models? [J].
Almonacid-Urrego, C. C. ;
Sanchez-Campos, S. ;
Tunon, M. J. ;
Gonzalez-Gallego, J. .
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (09) :1389-1404
[9]   Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease [J].
Araya, J ;
Rodrigo, R ;
Videla, LA ;
Thielemann, L ;
Orellana, M ;
Pettinelli, P ;
Poniachik, J .
CLINICAL SCIENCE, 2004, 106 (06) :635-643
[10]   Liver fatty acid-binding protein and obesity [J].
Atshaves, Barbara P. ;
Martin, Gregory G. ;
Hostetler, Heather A. ;
McIntosh, Avery L. ;
Kier, Ann B. ;
Schroeder, Friedhelm .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2010, 21 (11) :1015-1032